Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 8 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: May 4, 2026
Last action: Jul 8, 2026 — Approved P.L.2026, c.40.
Session: 222
Momentum: 70 · High

PASSAGE PROBABILITY

32.8% Uncertain

Why this number

Stage base Passed First Chamber — base rate 40%, measured from NJ's completed sessions
Momentum +4 70/100 from the pace of recorded action
Time since last action -12 94 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.